Area of research
Hepatology · Infectious Diseases
Research interest
Research interests include Hepatitis C virus research, HIV/AIDS drug development and treatment, Ocular Surface and Contact Lens, and Corneal surgery and disorders.
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study
Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses
Resistance analysis in patients with genotype 1–6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL Trials
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection
Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options